Search
Brimonidine
go.drugbank.com/drugs/DB00484ApprovedInvestigationalBecause it is oxidately stable, brimonidine is associated with fewer reports of ocular allergic reactions compared to other alpha-2 adrenergic agonists.
Mixtures: Brim-Dor PF, Tim-Brim-Dor PFProducts: Dom-brimonidineCetirizine
go.drugbank.com/drugs/DB00341ApprovedInvestigationalCetirizine, also commonly known as Zyrtec, is an orally active second-generation histamine H1 antagonist proven effective in the treatment of various allergic symptoms, such as sneezing, coughing, nasal congestion, hives, and other sympt...
Mixtures: BRONQUISOL GRIP GRANULADO PARA RECONSTITUIRProducts: Dom-cetirizine, CETIRIZINA DOCLeuvectin
go.drugbank.com/drugs/DB17303InvestigationalLeuvectin (formerly known as VCL-1102) is a component of gene therapy along with cationic lipid 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE).
Synonyms: DNA-lipid complex (DMRIE/DOPE)/plasmid vector (VCL-1102, Vical) expressing human interleukin-2Categories: Complex MixturesStannous fluoride
go.drugbank.com/drugs/DB11092ApprovedInvestigationalStannous Fluoride, or Tn(II) Fluoride, is a compound commonly used in toothpastes for the prevention of gingivitis, dental infections, cavities, and to relieve dental hypersensitivity. Although similar in function and activity to Sodium ...
Products: Gel-kam Fluorocare Part B-mint, Gel-kam Fluorocare Part B-bubblegumLevocarnitine
go.drugbank.com/drugs/DB00583ApprovedInvestigationalConstituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
Products: CARNITENE 1 G TEK DOZ ORAL SOLÜSYON, 10 MLPseudoephedrine
go.drugbank.com/drugs/DB00852Approved[A188823] The decongestant effect of pseudoephedrine was described in dogs in 1927.[A188823]
Mixtures: Vaso Dose Pack, VisRx Dose PackProducts: Pseudoephedrine HCl Unit DoseVorapaxar
go.drugbank.com/drugs/DB09030ApprovedBy inhibiting PAR-1, a thrombin receptor expressed on platelets, vorapaxar prevents thrombin-related platelet aggregation. … Vorapaxar is a tricyclic himbacine-derived selective inhibitor of protease activated receptor (PAR-1) indicated for reducing the incidence of thrombotic cardiovascular events in patients with a history
Categories: Receptor, PAR-1, antagonists & inhibitorsTicagrelor
go.drugbank.com/drugs/DB08816ApprovedInvestigational[A2903] It is marketed by Astra Zeneca as Brilinta in the US[L14201] and Brilique or Possia in the EU,[L14207]. Ticagrelor was granted EMA approval on 3 December 2010.
Products: TICAGRELOR DOCHydrochlorothiazide
go.drugbank.com/drugs/DB00999ApprovedInvestigationalVet approvedHydrochlorothiazide is the most commonly prescribed thiazide diuretic. It is indicated to treat edema and hypertension. Hydrochlorothiazide use is common but declining in favour of angiotensin converting enzyme inhibitors. Many combinati...
Mixtures: Ser-Ap-Es, Ser-AP-ES TabCategories: Genito Urinary System and Sex Hormones